These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38310907)

  • 1. Will two doses of pneumococcal conjugate vaccine be enough?
    Russell FM; Chokephaibulkit K
    Lancet Infect Dis; 2024 May; 24(5):449-451. PubMed ID: 38310907
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the new pneumococcal conjugate vaccine in the USA.
    Baucher H
    Arch Dis Child; 2000 Nov; 83(5):396. PubMed ID: 11040145
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumococcal immunization with conjugate vaccines: are 10-valent and 13-valent vaccines similar?
    Esposito S; Principi N
    Future Microbiol; 2019 Jul; 14():921-923. PubMed ID: 31373218
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
    Weiser JN; Austrian R
    Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule.
    Fritzell B; Fletcher MA
    Expert Rev Vaccines; 2011 Mar; 10(3):263-90. PubMed ID: 21434795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China.
    Chen JJ; Yuan L; Huang Z; Shi NM; Zhao YL; Xia SL; Li GH; Li RC; Li YP; Yang SY; Xia JL
    BMJ Open; 2016 Oct; 6(10):e012488. PubMed ID: 27798013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the use of pneumococcal conjugate vaccine globally.
    O'Brien KL
    JAMA; 2013 Sep; 310(9):911-3. PubMed ID: 24002275
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistence of pneumococcal antibodies after primary immunisation with a polysaccharide-protein conjugate vaccine.
    Zimmermann P; Perrett KP; Berbers G; Curtis N
    Arch Dis Child; 2019 Jul; 104(7):680-684. PubMed ID: 30796020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conjugated pneumococcal vaccines].
    Reinert P
    Arch Pediatr; 1999; 6 Suppl 3():643s-646s. PubMed ID: 10429806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
    Haveman LM; Geelen SP; Sanders EA; Wolfs TF
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the new pneumococcal conjugate vaccine.
    Holland MJ
    Pediatr Ann; 2001 Sep; 30(9):515-6. PubMed ID: 11554259
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK.
    Ladhani SN; Andrews N; Ramsay ME
    Lancet Infect Dis; 2021 Apr; 21(4):e93-e102. PubMed ID: 33129426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
    Goldblatt D; Southern J; Ashton L; Richmond P; Burbidge P; Tasevska J; Crowley-Luke A; Andrews N; Morris R; Borrow R; Cartwright K; Miller E
    Pediatr Infect Dis J; 2006 Apr; 25(4):312-9. PubMed ID: 16567982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.
    Gladstone RA; Jefferies JM; Faust SN; Clarke SC
    Expert Rev Vaccines; 2012 Aug; 11(8):889-902. PubMed ID: 23002969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccine--prospects for intervention in children.
    Madhi SA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):285-94. PubMed ID: 10501316
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of pneumococcal disease in the United Kingdom--the start of a new era.
    Clarke SC
    J Med Microbiol; 2006 Aug; 55(Pt 8):975-980. PubMed ID: 16849715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
    Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
    Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.